支气管动脉灌注治疗中晚期肺癌40例疗效分析
肺癌;支气管动脉;治疗,,],肺癌;支气管动脉;治疗,1材料和方法,2结果,3讨论,参考文献:
[摘要] 目的:评价支气管动脉灌注(bronchial arterial infusion,BAI)化疗药物治疗中晚期肺癌的疗效及安全性。方法:对40例中晚期肺癌患者行支气管动脉插管,通过支气管动脉灌注化疗药物。采用顺铂(DDP)50 mg~60 mg或卡铂(CBP)300 mg~500 mg、丝裂霉素(MMC)10 mg和阿霉素(ADM)50 mg三联药物,40例共行88次BAI治疗。结果:40例患者中完全缓解(CR)4例,部分缓解(PR)24例,稳定(SD)9例,进展(PD)3例,有效率(CR+PR)为70.0%,1 a生存率为62.5%。鳞癌和富血供肺癌的BAI疗效分别优于腺癌和乏血供者(P<0.01)。结论:支气管动脉灌注治疗中晚期肺癌安全有效。[关键词] 肺癌;支气管动脉;治疗
The Evaluation of Bronchial Arterial Infusion Chemotherapy Effect on Midadvanced Lung Cancer
HOU Wenzhong,YU Zhao,QIU Weijiang
(Meizhou People's Hosipital,Meizhou,Guangdong 514031, China)
Abstract:Objective clinical chemotherapy effect and safety of bronchial arterial infusion (BAI) in the midadvanced lung cancer.Methods Forty patients of midadvanced lung cancer confirmed by pathologhy received BAI treatment.In the combination of chemotherapy medicine,they were DDP (50 mg~60 mg) or CBP (300 mg~500 mg),MMC (10 mg) and ADM (50 mg).There were total 88 BAI in 40 patients.Results In 40 patients,there were 4 cases of complete response ......
您现在查看是摘要页,全文长 7364 字符。